Table 2

Multivariable regression models for predictors of (A) NIHSS shift; (B) modified Rankin Scale at discharge and (C) modified Rankin Scale at follow-up

Beta95% CI* p Value*
(A) NIHSS shift
 Thrombectomy−3.74−6.02−1.500.016
 Gender (M)−2.55−5.38−.1350.147
 CTA collateral−1.26−3.090.060.206
 Age0.03−.0210.080.284
 Intravenous tPA−0.12−3.563.570.951
 MCA M2 0.08−2.332.760.960
 MCA M1 0.01−2.662.120.993
 Basilar 0.36−3.656.790.899
(B) Good outcome at discharge
 Thrombectomy−21.85−41.35−20.770.002
 MCA M10.89−0.512.630.175
 Gender (M)0.68−0.292.100.201
 Intravenous tPA0.64−1.6320.570.425
 Baseline NIHSS0.10−0.170.430.463
 Intracranial ICA0.23−1.211.700.716
 Basilar−0.32−4.722.350.775
 Age0.01−.0340.050.791
 CTA collateral0.01−0.880.810.978
(C) Good outcome at long-term follow-up
 Thrombectomy−21.11−39.07−19.700.003
 Intravenous tPA0.90−1.2019.890.216
 Intracranial ICA−0.84−21.090.670.264
 CTA collateral−0.47−2.320.250.280
 Basilar−1.36−23.811.080.389
 MCA M1−0.56−3.320.890.469
 Baseline NIHSS0.10−0.240.480.509
 Age−0.00−0.060.050.796
 Gender (M)0.13−1.392.150.857
  • *Bootstrap results based on 2000 samples.

  • †compared with intracranial ICA occlusions.

  • CTA, CT angiography; ICA, intracranial carotid artery; MCA, middle cerebral artery; NIHSS, National Institute of Health Stroke Scale; tPA, tissue plasminogen activator.